Liguori, S.; Musella, G.; Adamo, D.; Miele, E.; Coppola, N.; Canfora, F.; Del Giudice, C.; Spagnuolo, G.; Rengo, S.; Mignogna, M.D.;
et al. Salivary Calprotectin as a Biomarker in Early Onset Inflammatory Bowel Disease: A Pilot Study. J. Clin. Med. 2025, 14, 4232.
https://doi.org/10.3390/jcm14124232
AMA Style
Liguori S, Musella G, Adamo D, Miele E, Coppola N, Canfora F, Del Giudice C, Spagnuolo G, Rengo S, Mignogna MD,
et al. Salivary Calprotectin as a Biomarker in Early Onset Inflammatory Bowel Disease: A Pilot Study. Journal of Clinical Medicine. 2025; 14(12):4232.
https://doi.org/10.3390/jcm14124232
Chicago/Turabian Style
Liguori, Simone, Gennaro Musella, Daniela Adamo, Erasmo Miele, Noemi Coppola, Federica Canfora, Carmela Del Giudice, Gianrico Spagnuolo, Sandro Rengo, Michele Davide Mignogna,
and et al. 2025. "Salivary Calprotectin as a Biomarker in Early Onset Inflammatory Bowel Disease: A Pilot Study" Journal of Clinical Medicine 14, no. 12: 4232.
https://doi.org/10.3390/jcm14124232
APA Style
Liguori, S., Musella, G., Adamo, D., Miele, E., Coppola, N., Canfora, F., Del Giudice, C., Spagnuolo, G., Rengo, S., Mignogna, M. D., & Leuci, S.
(2025). Salivary Calprotectin as a Biomarker in Early Onset Inflammatory Bowel Disease: A Pilot Study. Journal of Clinical Medicine, 14(12), 4232.
https://doi.org/10.3390/jcm14124232
